Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Virtual Meeting, 31751-31752 [2020-11336]

Download as PDF jbell on DSKJLSW7X2PROD with NOTICES Federal Register / Vol. 85, No. 102 / Wednesday, May 27, 2020 / Notices necessary, and would be used, to provide staff with a sufficient basis for determining whether: (1) Granting the relief would be necessary or appropriate under the facts and circumstances presented by the requestor; (2) the relief provided should be conditional and/or time-limited; and (3) granting the relief would be consistent with staff responses to requests that have been presented under similar facts and circumstances. In some cases, the requested relief might be granted upon the requirement that those who seek the benefits of that relief fulfill certain conditions that are necessary to ensure that the relief granted by Commission staff is appropriate. Once again, it is likely that those who would comply with these conditions will have determined that the sought relief outweighs the compliance burden. This information collection also is necessary to provide a mechanism whereby persons requesting interpretative, no-action, and exemptive letters may seek temporary confidential treatment of their request and the Commission staff response thereto and the grounds upon which such confidential treatment is sought. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. On March 18, 2020, the Commission published in the Federal Register notice of the proposed extension of this information collection and provided 60 days for public comment on the proposed extension, 85 FR 15436 (‘‘60-Day Notice’’). The Commission did not receive any relevant comments on the 60-Day Notice. Accordingly, the Commission believes that the burden estimate described in the 60-Day Notice is appropriate. Burden Statement: The Commission is revising its estimate of the burden for this collection for persons registered with the Commission (such as commodity pool operators, commodity trading advisors, derivatives clearing organizations, designated contract markets, futures commission merchants, introducing brokers, swap dealers, and swap execution facilities), persons seeking an exemption from registration, persons whose registration with the Commission is pending, trade associations and their members, eligible contract participants, and other persons seeking relief from discrete regulatory requirements. The respondent burden for this collection is estimated to be as follows: Estimated Number of Respondents: 68. VerDate Sep<11>2014 16:59 May 26, 2020 Jkt 250001 Estimated Average Burden Hours per Respondent: 40. Estimated Total Annual Burden Hours: 2,720. Frequency of Collection: Occasional. There are no capital costs or operating and maintenance costs associated with this collection. (Authority: 44 U.S.C. 3501 et seq.) Dated: May, 20, 2020. Robert Sidman, Deputy Secretary of the Commission. [FR Doc. 2020–11296 Filed 5–26–20; 8:45 am] BILLING CODE 6351–01–P COMMODITY FUTURES TRADING COMMISSION Sunshine Act Meetings 10:00 a.m. EDT, Thursday, May 28, 2020. TIME AND DATE: PLACE: Conference call. STATUS: Open. The Commodity Futures Trading Commission (‘‘Commission’’ or ‘‘CFTC’’) will hold this meeting to consider the following matters: • Proposed Rule: Amendments to Regulation 3.10(c)(3)—Providing an Exemption from Registration for Foreign Persons Acting as Commodity Pool Operators on Behalf of Offshore Commodity Pools; and • Interim Final Rule: Amendments to Regulation 23.161—Extending the Compliance Schedule for Initial Margin Requirements for Uncleared Swaps in Response to the COVID–19 Pandemic. The agenda for this meeting will be available to the public and posted on the Commission’s website at https:// www.cftc.gov. Instructions for public access to the live audio feed of the meeting will also be posted on the Commission’s website. In the event that the time, date, or place of this meeting changes, an announcement of the change, along with the new time, date, or place of the meeting, will be posted on the Commission’s website. MATTERS TO BE CONSIDERED: CONTACT PERSON FOR MORE INFORMATION: Christopher Kirkpatrick, Secretary of the Commission, 202–418–5964. Authority: 5 U.S.C. 552b. Dated: May 21, 2020. Christopher Kirkpatrick, Secretary of the Commission. [FR Doc. 2020–11409 Filed 5–22–20; 11:15 am] BILLING CODE 6351–01–P PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 31751 DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Virtual Meeting Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. DATES: Open to the public Wednesday, June 24, 2020, from 1:00 p.m. to 2:00 p.m. (Eastern Daylight Time). ADDRESSES: The address of the open meeting will be online. The phone number for the remote access is: CONUS: 888–469–2037; OCONUS: 1– 517–308–9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in instructions will also be posted on the Uniform Formulary Beneficiary Advisory Panel website at: https:// www.health.mil/About-MHS/OASDHA/ Defense-Health-Agency/Operations/ Pharmacy-Division/BeneficiaryAdvisory-Panel. FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703– 681–2890 (Voice), None (Facsimile), dha.ncr.j-6.mbx.baprequests@mail.mil (Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042–5101. Website: https://www.health.mil/About-MHS/ Other-MHS-Organizations/BeneficiaryAdvisory-Panel. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102–3.140 and 102–3.150. The Panel will review and comment on recommendations made to the Director, Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Purpose of the Meeting: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. Agenda: 1. Sign-In 2. Welcome and Opening Remarks SUMMARY: E:\FR\FM\27MYN1.SGM 27MYN1 31752 Federal Register / Vol. 85, No. 102 / Wednesday, May 27, 2020 / Notices 3. Newly Approved Drugs Review 4. Pertinent Utilization Management Issues 5. Panel Discussions and Vote Meeting Accessibility: Pursuant to 5 U.S.C. 552b, and 41 CFR 102–3.140 through 102–3.165, and the subject to availability of phone lines, this meeting is open to the public. Access is limited and will be provided only to the first 220 people dialing in. There will be 220 lines total: 200 domestic and 20 international, including leader lines. Written Statements: Pursuant to 41 CFR 102–3.10, and section 10(a)(3) of FACA, interested persons or organizations may submit written statements to the Uniform Formulary Beneficiary Advisory Panel about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the Uniform Formulary Beneficiary Advisory Panel’s Designated Federal Officer (DFO). The DFO’s contact information can be found in the FOR FURTHER INFORMATION CONTACT section of this notice. Written comments or statements must be received by the Uniform Formulary Beneficiary Advisory Panel’s DFO at least five (5) business days prior to the meeting so they may be made available to the Uniform Formulary Beneficiary Advisory Panel for its consideration prior to the meeting. The DFO will review all submitted written statements and provide copies to all Uniform Formulary Beneficiary Advisory Panel members. Dated: May 21, 2020. Aaron T. Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2020–11336 Filed 5–26–20; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Reserve Forces Policy Board; Notice of Federal Advisory Committee Meeting Under Secretary of Defense for Personnel and Readiness, Department of Defense (DoD). AGENCY: Notice of Federal Advisory Committee meeting. jbell on DSKJLSW7X2PROD with NOTICES ACTION: The DoD is publishing this notice to announce that the following Federal Advisory Committee meeting of the Reserve Forces Policy Board (RFPB) will take place. SUMMARY: VerDate Sep<11>2014 16:59 May 26, 2020 Jkt 250001 The RFPB will hold an open to the public meeting on Wednesday, June 3, 2020 from 8:55 a.m. to 12:10 p.m. ADDRESSES: The RFPB meeting will be online using Microsoft Teams CVR and Teleconference line. To participate in the meeting, see the Meeting Accessibility section for instructions. FOR FURTHER INFORMATION CONTACT: Alexander Sabol, (703) 681–0577 (Voice), 703–681–0002 (Facsimile), alexander.j.sabol.civ@mail.mil (Email). Mailing address is Reserve Forces Policy Board, 5113 Leesburg Pike, Suite 601, Falls Church, VA 22041. Website: https://rfpb.defense.gov/. The most upto-date changes to the meeting agenda can be found on the website and the Federal Register. SUPPLEMENTARY INFORMATION: Due to circumstances beyond the control of the Department of Defense and the Designated Federal Officer, the Reserve Forces Policy Board was unable to provide public notification required by 41 CFR 102–3.150(a) concerning its meeting of June 3, 2020. Accordingly, the Advisory Committee Management Officer for the Department of Defense, pursuant to 41 CFR 102–3.150(b), waives the 15-calendar day notification requirement. This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) (5 U.S.C., Appendix), the Government in the Sunshine Act (5 U.S.C. 552b), and 41 CFR 102–3.140 and 102–3.150. Purpose of the Meeting: The purpose of the meeting is to obtain, review, and evaluate information related to strategies, policies, and practices designed to improve and enhance the capabilities, efficiency, and effectiveness of the Reserve Components. Agenda: The RFPB will hold an online open to the public meeting on Wednesday, June 3, 2020 from 8:55 a.m. to 12:10 p.m. The meeting will consist of remarks to the RFPB from the following invited speakers: Under Secretary of Defense for Personnel and Readiness will discuss the goals of the Under Secretary of Defense for Personnel and Readiness, the Department’s response to the coronavirus disease 2019 (COVID–19), and potential changes to future policy necessitated by the response; the Deputy Commander, United States Northern Command (USNORTHCOM) will discuss the Reserve Components’ role in USNORTHCOM’s response to COVID 19 and recommended force structure/ policy changes for future domestic response operations; the Navy Emergency Preparedness Liaison Officer DATES: PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 (EPLO) for USNORTHCOM will discuss the role of EPLOs in COVID 19 response operations and speak to actions at the tactical level, focusing on lessons learned and recommendations for future disaster response efforts; the New York State Commissioner of the Division of Homeland Security and Emergency Services will discuss New York’s perspective on the effectiveness of the partnership of the State, FEMA, and Department of Defense in COVID 19 response efforts, and provide recommendations to enhance future collaboration between entities; the Deputy Assistant Secretary Defense for Reserve Integration will discuss the impact of COVID 19 on the Reserve Components’ readiness, discussing policies that hindered readiness, comparing best practices, and providing recommended future policy changes to preserve and enhance readiness during periods of distributed operations; and the Subcommittee on Supporting and Sustaining Reserve Component Personnel will discuss the Board’s review of and make suggestions for the Department’s New Administration Transition Book that will provide recommendations on strategies to enhance the future capabilities and effectiveness of the Reserve Components and Department as a whole, to include potential rebalancing of Active/Reserve future force structure. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended and 41 CFR 102–3.140 through 102–3.165, and subject to the availability of space, the meeting is open online to the public from 8:55 a.m. to 12:10 p.m. Persons desiring to participate in the meeting online or by phone are required to submit their name, organization, email and telephone contact information to COL Christopher Warner at christopher.w.warner3.mil@mail.mil not later than Friday, May 29, 2020. Specific instructions, both for online or teleconference participation in the meeting, will be provided by reply email. The meeting agenda will be available prior to the meeting on the Board’s website at: https:// rfpb.defense.gov/. Written Statements: Pursuant to section 10(a)(3) of the FACA and 41 CFR 102–3.105(j) and 102–3.140, interested persons may submit written statements to the RFPB about its approved agenda or at any time on the RFPB’s mission. Written statements should be submitted to the RFPB’s Designated Federal Officer (DFO) at the address, email, or facsimile number listed in the FOR FURTHER INFORMATION CONTACT section. If statements pertain to a specific topic being discussed at the planned meeting, E:\FR\FM\27MYN1.SGM 27MYN1

Agencies

[Federal Register Volume 85, Number 102 (Wednesday, May 27, 2020)]
[Notices]
[Pages 31751-31752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11336]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee Virtual Meeting

AGENCY: Under Secretary of Defense for Personnel and Readiness, 
Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY: The DoD is publishing this notice to announce that the 
following Federal Advisory Committee meeting of the Uniform Formulary 
Beneficiary Advisory Panel will take place.

DATES: Open to the public Wednesday, June 24, 2020, from 1:00 p.m. to 
2:00 p.m. (Eastern Daylight Time).

ADDRESSES: The address of the open meeting will be online. The phone 
number for the remote access is: CONUS: 888-469-2037; OCONUS: 1-517-
308-9287; PARTICIPANT CODE: 8227323. These numbers and the dial-in 
instructions will also be posted on the Uniform Formulary Beneficiary 
Advisory Panel website at: https://www.health.mil/About-MHS/OASDHA/Defense-Health-Agency/Operations/Pharmacy-Division/Beneficiary-Advisory-Panel.

FOR FURTHER INFORMATION CONTACT: Colonel Paul J. Hoerner, USAF, 703-
681-2890 (Voice), None (Facsimile), [email protected] (Email). Mailing address is 7700 Arlington 
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/About-MHS/Other-MHS-Organizations/Beneficiary-Advisory-Panel. The most up-to-date changes to the meeting agenda can be found 
on the website.

SUPPLEMENTARY INFORMATION: This meeting is being held under the 
provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 
U.S.C., Appendix, as amended), the Government in the Sunshine Act of 
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
    The Panel will review and comment on recommendations made to the 
Director, Defense Health Agency, by the Pharmacy and Therapeutics 
Committee, regarding the Uniform Formulary.
    Purpose of the Meeting: The DoD is publishing this notice to 
announce that the following Federal Advisory Committee meeting of the 
Uniform Formulary Beneficiary Advisory Panel will take place.
Agenda:
1. Sign-In
2. Welcome and Opening Remarks

[[Page 31752]]

3. Newly Approved Drugs Review
4. Pertinent Utilization Management Issues
5. Panel Discussions and Vote
    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, and 41 CFR 102-
3.140 through 102-3.165, and the subject to availability of phone 
lines, this meeting is open to the public. Access is limited and will 
be provided only to the first 220 people dialing in. There will be 220 
lines total: 200 domestic and 20 international, including leader lines.
    Written Statements: Pursuant to 41 CFR 102-3.10, and section 
10(a)(3) of FACA, interested persons or organizations may submit 
written statements to the Uniform Formulary Beneficiary Advisory Panel 
about its mission and/or the agenda to be addressed in this public 
meeting. Written statements should be submitted to the Uniform 
Formulary Beneficiary Advisory Panel's Designated Federal Officer 
(DFO). The DFO's contact information can be found in the FOR FURTHER 
INFORMATION CONTACT section of this notice. Written comments or 
statements must be received by the Uniform Formulary Beneficiary 
Advisory Panel's DFO at least five (5) business days prior to the 
meeting so they may be made available to the Uniform Formulary 
Beneficiary Advisory Panel for its consideration prior to the meeting. 
The DFO will review all submitted written statements and provide copies 
to all Uniform Formulary Beneficiary Advisory Panel members.

    Dated: May 21, 2020.
Aaron T. Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2020-11336 Filed 5-26-20; 8:45 am]
BILLING CODE 5001-06-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.